Glucagon Emergency Kit for Low Blood Sugar recall
FDA recall D-0723-2026 · initiated Jun 23, 2026
Lupin Pharmaceuticals Inc. recalled Glucagon Emergency Kit for Low Blood Sugar in Jun 2026 — an FDA Class II recall (D-0723-2026) because CGMP deviation: OOS result observed for the Gliding Force functionality test during 12-month long term stability testing.
May cause temporary or medically reversible harm; low probability of serious harm.
Why it was recalled
CGMP deviation: OOS result observed for the Gliding Force functionality test during 12-month long term stability testing.
Wrong strength, or it did not keep
The product did not contain what the label promised, or stopped meeting specification before its expiry date. Under-strength medicine can mean an untreated condition.
This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.
Is your product affected? Check the lot number
A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.
Quantity recalled: 64,894 units
Details
- Product
- Glucagon Emergency Kit for Low Blood Sugar, Glucagon for Injection USP, 1mg per vial, Diluent for Glucagon, 1 mL syringe, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, Manufactured by: Lupin Limited, Nagpur - 441108, INDIA, NDC 70748-311-01
- Recalling company
- Lupin Limited
- Classification
- Class II
- Status
- Ongoing
- Type
- Voluntary: Firm initiated
- Distribution
- Nationwide within the U.S.
- Initiated
- Jun 23, 2026
- FDA report date
- Jul 8, 2026
Frequently asked
- Was Glucagon Emergency Kit for Low Blood Sugar recalled?
- Lupin Pharmaceuticals Inc. recalled Glucagon Emergency Kit for Low Blood Sugar in Jun 2026 — an FDA Class II recall (D-0723-2026) because CGMP deviation: OOS result observed for the Gliding Force functionality test during 12-month long term stability testing. May cause temporary or medically reversible harm; low probability of serious harm.
- Why was Glucagon Emergency Kit for Low Blood Sugar recalled?
- Per the FDA enforcement record, the reason for recall D-0723-2026 was: CGMP deviation: OOS result observed for the Gliding Force functionality test during 12-month long term stability testing.
- Is a recalled Glucagon Emergency Kit for Low Blood Sugar dangerous to take?
- An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
- Which lots of Glucagon Emergency Kit for Low Blood Sugar are affected?
- Distributed: Nationwide within the U.S.. The recall covers these lots — Kit Lots: WB00010, Exp. Date Jan 2027; WB00017, WB00019, Exp. Date Feb 2027; WB00070, Exp. Date Jun 2027; WB00077, WB00078, Exp. Date Jul 2027; WB00130, Exp. Date Nov 2027.. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0723-2026.